Treatment of respiratory diseases

Details for Australian Patent Application No. 2006329199 (hide)

Owner UTI Limited Partnership

Inventors Schurch, Samuel; El Mays, Tamer Y.; Green, Francis H. y.

Agent FB Rice

Pub. Number AU-A-2006329199

PCT Pub. Number WO2007/071052

Priority 60/597,841 21.12.05 US

Filing date 21 December 2006

Wipo publication date 28 June 2007

International Classifications

A61K 33/00 (2006.01) Medicinal preparations containing inorganic active ingredients

A61K 31/02 (2006.01) - Halogenated hydrocarbons

A61K 31/131 (2006.01) - acyclic

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/352 (2006.01) - condensed with carbocyclic rings, e.g. cannabinols, methantheline

Event Publications

3 July 2008 PCT application entered the National Phase

  PCT publication WO2007/071052 Priority application(s): WO2007/071052

18 August 2011 Assignment before Grant

  UTI Limited Partnership The application has been assigned to SolAreaMed Inc.

8 September 2011 Corrigenda

  Assignments Before Grant, Section 113 - 2006 Under the name SolAreaMed Inc., Application No. 2006329199 under INID(71), correct the name to read SolAeroMed Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006329202-Compositions and methods for modulating gated ion channels

2006329198-Novel cancer-associated antigen